The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial.
Magnifica historia, biográfica y científica, del descubrimiento e implicaciones del método CRISPr que valió el premio Nobel a sus dos descubridores.
The results of this post hoc analysis support the hypothesis that benralizumab reduces the risk for recurrent COPD exacerbations within the vulnerable 30-to-90–day period in the previously identified responder population.
Mediante esta noticia ponemos a vuestra disposición los documentos de las presentaciones de Alvar Agustí durante la sesión del Webinar «JOINT WEBINAR ON COPD 2023 GUIDELINES»
Joint webinar on GOLD COPD GUIDELINES, Next Saturday, 12 August 2023 from 8:00 to 9:10 (CEST/UTC+2)
GOLD Scientific Committee responses the five letters received in relation to the recent publication of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023.
COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.
The use of biologic therapies, including monoclonal antibodies, has revolutionized the treatment of many human diseases.
Senescencia y progresión a daño orgánico en las enfermedades crónicas inmunomediadas: ¿Podemos prevenirlo?
It is now well established that there are different life-long lung function trajectories in the general population, and that some are associated with better or worse health outcomes.
